Amgen Inc. is a leading biotechnology company founded in 1980 by scientists from the University of California.
Having commenced its businesses by developing innovative therapeutics for serious illnesses, Amgen has grown into a global biopharmaceutical powerhouse.
Their primary focus areas include oncology, cardiovascular disease, inflammation, and neuroscience.
Amgen’s success is marked by groundbreaking drugs like Epogen, Neulasta, and Enbrel, which have significantly impacted patient care.
The company has expanded its portfolio through strategic acquisitions, including the purchase of Immunex Corporation in 2002, bolstering its presence in immunology.
In 2019, Amgen acquired worldwide rights to Otezla from Celgene, strengthening its position in treating autoimmune diseases.
While many of us know how pleasant a listing gain is, Amgen Inc. started with a listing loss of around 77% – the share remained bearish until November 1984.
However, if we look at its share price now, it has grown by 1,22,027% and is traded at $316 in February 2024 from $0.2708 on its listing date, i.e., June 1983.
Amgen Share Price History
Year | Share Price | Gain / Loss |
---|---|---|
1983 | $ 0.15 | |
1984 | $ 0.10 | - 33.3% |
1985 | $ 0.28 | + 180.0% |
1986 | $ 0.46 | + 64.3% |
1987 | $ 0.65 | + 41.3% |
1988 | $ 0.70 | + 7.7% |
1989 | $ 1.02 | + 45.7% |
1990 | $ 2.59 | + 153.9% |
1991 | $ 9.47 | + 265.6% |
1992 | $ 8.83 | - 6.8% |
1993 | $ 6.19 | - 29.9% |
1994 | $ 7.38 | + 19.2% |
1995 | $ 14.84 | + 101.1% |
1996 | $ 13.59 | - 8.4% |
1997 | $ 13.53 | - 0.4% |
1998 | $ 26.14 | + 93.2% |
1999 | $ 60.06 | + 129.8% |
2000 | $ 63.94 | + 6.5% |
2001 | $ 56.44 | - 11.7% |
2002 | $ 48.34 | - 14.4% |
2003 | $ 61.79 | + 27.8% |
2004 | $ 64.15 | + 3.8% |
2005 | $ 78.86 | + 22.9% |
2006 | $ 68.31 | - 13.4% |
2007 | $ 46.44 | - 32.0% |
2008 | $ 57.75 | + 24.4% |
2009 | $ 56.57 | - 2.0% |
2010 | $ 54.90 | - 3.0% |
2011 | $ 64.21 | + 17.0% |
2012 | $ 86.20 | + 34.2% |
2013 | $ 114.08 | + 32.3% |
2014 | $ 159.29 | + 39.6% |
2015 | $ 162.33 | + 1.9% |
2016 | $ 146.21 | - 9.9% |
2017 | $ 173.90 | + 18.9% |
2018 | $ 194.67 | + 11.9% |
2019 | $ 241.07 | + 23.8% |
2020 | $ 229.92 | - 4.6% |
2021 | $ 224.97 | - 2.2% |
2022 | $ 262.64 | + 16.7% |
2023 | $ 288.02 | + 9.7% |
2024 | $ 260.64 | - 9.5% |
2025 | $ 307.81 | + 18.1% |
Amgen Share Price Chart

Amgen Share Returns Calculator
Enter any amount in the 'Investment amount' field and select a year.
The Amgen calculator will tell you the value of your Amgen investment in 2025.
Invested Amount
Investment Year
- During 1983, the share price of Amgen was $ 0.15.
- If you had bought shares worth $ 2500 in 1983, you would have 166667 shares today.
- At the end of 2025, the current value of your shares would be $ 51301667.
Amgen Share Returns Comparison
Invested Amount
Investment Year
Other Investment
Interest Rate